Piro Lito
MD, PhD
Associate Member
👥Biography 个人简介
Piro Lito discovered the adaptive feedback reactivation mechanism that limits KRAS G12C inhibitor efficacy, defining the biological rationale for combination therapies. His laboratory research at MSKCC has identified SHP2 and SOS1 as key mediators of adaptive resistance. His work has directly informed clinical combination strategies in later-line settings.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Piro Lito 的研究动态
Follow Piro Lito's research updates
留下邮箱，当我们发布与 Piro Lito（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment